Skip to content
TheChatArchiveThe Chat Archive
Grok 4.1 Fast· xaiHugging Face Frontier Reasoning Traces

Develop a cross-specialty long COVID consensus guideline process with Delphi rounds,…

  1. User

    Develop a cross-specialty long COVID consensus guideline process with Delphi rounds, living literature review, and dissemination strategy.

  2. Assistant

    Cross-Specialty Long COVID Consensus Guideline Development Process

    Overview and Objectives

    This process outlines a rigorous, transparent, and adaptable framework for developing living consensus guidelines on long COVID (post-acute sequelae of SARS-CoV-2 infection). It integrates a multidisciplinary Delphi method for expert consensus, a living systematic literature review for evidence integration, and a multi-channel dissemination strategy to ensure rapid uptake.

    Key Objectives:

    • Achieve ≥80% consensus on key recommendations across specialties (e.g., pulmonology, cardiology, neurology, immunology, rheumatology, psychology, primary care, rehabilitation).
    • Produce actionable, evidence-based guidelines on diagnosis, risk stratification, management, rehabilitation, and research priorities.
    • Enable continuous updates as new evidence emerges.
    • Promote equity by including global experts from diverse regions and underrepresented groups.

    Guideline Scope: Modular sections covering symptoms (fatigue, dyspnea, cognitive impairment, dysautonomia), diagnostics, therapeutics, multidisciplinary care pathways, and patient-centered outcomes.

    Timeline: Initial guidelines in 6-9 months; quarterly updates thereafter.

    Governance: Overseen by a Steering Committee (10-15 members: methodologists, clinicians, patients, policymakers).

    Step 1: Preparation and Panel Assembly (Months 1-2)

    • Steering Committee Formation: Recruit via professional societies (e.g., ATS, ESC, AAN), patient advocacy groups (e.g., Long COVID SOS), and WHO/CDC networks. Include 2-3 patient representatives.
    • Expert Panel Recruitment: 50-100 experts (20-30 per specialty cluster: respiratory/cardio; neuro/psych; immune/rheum; rehab/primary care). Criteria: ≥5 years clinical/research experience in COVID/long COVID; geographic diversity; no major conflicts of interest (managed via disclosure).
      • Use snowball sampling and open calls via platforms like ResearchGate and specialty journals.
    • Tools Setup:
      • Secure online platform (e.g., REDCap or DelphiManager) for anonymous surveys.
      • Living review infrastructure: Automated PubMed/Embase/Cochrane alerts + AI screening (e.g., DistillerSR or ASReview).

    Step 2: Living Systematic Literature Review (Ongoing, Starting Month 1)

    • Methodology: Follow PRISMA-Living guidelines.
      • Search Strategy: Weekly automated searches (MeSH: "Post-Acute COVID-19 Syndrome" OR "Long COVID"; filters: humans, English, post-2020). Include grey literature (preprints, guidelines).
      • Screening: Dual human-AI review (title/abstract → full-text). Risk-of-bias assessment (ROBINS-I for non-randomized studies; AMSTAR-2 for reviews).
      • Synthesis: GRADE-rated evidence summaries in living format (e.g., interactive Evidence-to-Decision tables via GRADEpro). Focus on PICO questions (e.g., "In long COVID patients with fatigue, does graded exercise therapy improve outcomes?").
    • Team: 5-7 reviewers (librarian, epidemiologist, 2 clinicians, AI specialist).
    • Outputs: Quarterly evidence briefs shared pre-Delphi rounds; version-controlled repository (e.g., GitHub or Zenodo).

    Step 3: Delphi Consensus Process (Months 2-5, Iterative)

    • Structure: 3-4 anonymous electronic rounds + virtual consensus meeting. Pre-defined consensus threshold: ≥80% agreement (Likert scale: 1-9; 7-9 = agree).
    • Round 1 (Open-Ended):
      • Distribute 20-30 draft statements (developed by Steering Committee + initial lit review).
      • Experts suggest additions/revisions.
    • Rounds 2-3 (Structured):
      • Present anonymized group statistics (median, IQR, % agreement).
      • Revised statements + rationale/justification fields.
      • Stable items removed; <50% agreement items discussed.
    • Round 4 (If Needed): Final voting with forced choice (agree/disagree).
    • Consensus Meeting (Month 5): Virtual (Zoom), 2-4 hours. Discuss <80% items live; vote via Slido. Record rationales.
    • Patient Input: Parallel patient Delphi (n=20-30) for lived experience statements.
    • Monitoring: Response rate target >80%; reminders via email/SMS.

    Example Statement: "We recommend multidisciplinary assessment for long COVID patients with ≥3 organ systems involved (GRADE: Moderate evidence; Consensus: 85%)."

    Step 4: Guideline Drafting and Approval (Months 5-6)

    • Integration: Steering Committee synthesizes Delphi outputs + living review into draft using AGREE II-compliant template.
      • Sections: Executive summary, methods, recommendations (with GRADE/strength), flowcharts, research gaps.
      • Visual aids: Algorithms, infographics (e.g., for primary care triage).
    • External Review: 20-30 independent reviewers (AGREE tool); 2-week feedback window.
    • Final Approval: ≥90% panel sign-off; minority opinions appended.

    Step 5: Dissemination and Implementation Strategy (Months 6+ Ongoing)

    • Core Principles: Open-access, multilingual (English + top 5 languages), patient-friendly versions.

    • Channels and Timeline:

      ChannelTacticsTimelineMetrics
      PublicationsLead paper in Lancet or BMJ; modular sections in specialty journals (e.g., Chest, Neurology). Preprint on medRxiv.Month 6; updates quarterlyCitations (>500/yr); Altmetric score >1,000
      Digital HubDedicated website (e.g., LongCOVIDGuidelines.org) with living PDF, app (iOS/Android), interactive tools.Launch Month 6100K visits/yr; app downloads >50K
      Professional NetworksEndorsement by societies (ATS, ERS); webinars; integration into UpToDate/Epocrates.Month 7+80% society adoption
      ConferencesPlenary sessions (e.g., ATS 2025); posters/booths.Ongoing5K attendees reached
      Social/OutreachTwitter/X threads (#LongCOVIDGuidelines); TikTok/YouTube explainers; patient org partnerships.Launch Month 61M impressions; 10K shares
      Policy/ImplementationBriefings to WHO/CDC/NICE; EHR integration (e.g., FHIR codes); audits in pilot clinics.Month 8+Policy citations; 20 clinics adopting
      Global EquityTranslations via Google/DeepL + experts; low-resource adaptations (e.g., WHO essential package).Month 9+Usage in 50+ countries
    • Evaluation: Annual audits (uptake surveys, guideline adherence studies). Feedback loop via website form.

    Step 6: Living Update Mechanism (Ongoing, Quarterly)

    • Triggers: New high-impact evidence (e.g., RCTs), Delphi re-vote if >10% shift.
    • Mini-Delphi: Subset panel (20-30) for rapid updates (<4 weeks).
    • Versioning: Semantic versioning (e.g., v1.2); changelog with GRADE re-assessments.
    • Sustainability: Funding via grants (NIH, Wellcome); volunteer core team.

    Resources and Risks

    • Budget Estimate: 500Kinitial(platform500K initial (platform 50K, personnel 300K,dissemination300K, dissemination 150K).
    • Risk Mitigation: COI management (annual declarations); bias audits; inclusivity quotas.
    • Success Metrics: Consensus rate ≥80%; guideline cited in >50% new long COVID papers; improved patient outcomes in audits.

    This process ensures evidence-driven, expert-consensus, adaptable guidelines that evolve with the science. For implementation, contact the Steering Committee lead.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.